Inhibitory effects of L-arginine derivatives on endothelium-dependent vasorelaxing response to acetylcholine of the rat aorta

European Journal of Medicinal Chemistry

Volumn 39, Issue 7, 2004, Pages 611-617

  Wang, Guei Jane ^a   Lai, Tzi Chung ^b   Chen, Chinpiao ^c  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL DONG HWA UNIVERSITY   (Taiwan)

Author keywords

N nitro L arginine alkyl esters; Nitric oxide synthase

Indexed keywords

AMINOGUANIDINE; ARGININE BENZYL ESTER; ARGININE BUTYL ESTER; ARGININE DECYL ESTER; ARGININE DERIVATIVE; ARGININE ETHYL ESTER; ARGININE HEPTYL ESTER; ARGININE HEXYL ESTER; ARGININE NONYL ESTER; ARGININE OCTYL ESTER; ARGININE PENTYL ESTER; ARGININE PROPYL ESTER; N(G) NITROARGININE BENZYL ESTER; N(G) NITROARGININE BUTYL ESTER; N(G) NITROARGININE DECYL ESTER; N(G) NITROARGININE ETHYL ESTER; N(G) NITROARGININE HEXYL ESTER; N(G) NITROARGININE METHYL ESTER; N(G) NITROARGININE NONYL ESTER; N(G) NITROARGININE OCTYL ESTER; N(G) NITROARGININE PENTYL ESTER; N(G) NITROARGININE PROPYL ESTER; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; CHEMICAL REACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SYNTHESIS; NONHUMAN; RAT; REACTION ANALYSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ARGININE; ENDOTHELIUM, VASCULAR; MUSCLE CONTRACTION; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 3242723310     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmech.2004.02.012     Document Type: Article

References (26)

1. Kerwin J.F. Jr, Lancaster J.R. Jr, Feldman P.F. J. Med. Chem. 38:1995;4343-4362
2. Stuehr D.J., Kwon N.S., Nathan C.F., Griffith O.W., Feldman P.L., Wiseman J. J. Biol. Chem. 266:1991;6259-6263
3. Griffith O.W., Stuehr D.J. Annu. Rev. Physiol. 57:1995;707-736
4. Knowles R.G., Moncada S. Biochem. J. 298:1994;249-258
5. Masters B.S., McMillan K., Sheta E.A., Nishimura J.S., Roman L.J., Martásek P. FASEB J. 10:1996;552-558
6. Li H., Raman C.S., Martásek P., Masters B.S.S., Poulos T.L. Biochemistry. 40:2001;5399-5406
7. Moncada S., Higgs A. New Engl. J. Med. 329:1993;2002-2012
8. Nathan C., Xie Q. Cell. 78:1994;915-918
9. Schmidt H.H., Walter U. Cell. 78:1994;919-925
10. Crane B.R., Arvai A.S., Gachhui R., Wu C., Ghosh D.K., Getzoff E.D., Stuehr D.J., Tainer J.A. Science. 278:1997;425-431
11. Mayer B., Werner E.R. Nauyn-Schmiedebergs Arch. Pharmacol. 351:1995;453-463
12. Stuehr D.J. Annu. Rev. Pharmacol. Toxicol. 37:1997;339-359
13. Abu-Soud H.M., Gachhui R., Raushel F.M., Stuehr D.J. J. Biol. Chem. 272:1997;17349-17353
14. Moncada S., Palmer R., Higgs E. Pharmacol. Rev. 43:1991;109-142
15. Radomski M., Palmer R., Moncada S. Lancet. 2:1987;1057-1058
16. Clozel M., Kuhn H., Hefti F., Baumgartner H. Hypertension. 18:1991;132-141
17. Garg U., Hassid A. J. Clin. Invest. 83:1989;1774-1777
18. Egashira K., Inou T., Hirooka Y., Yamada A., Maruoka Y., Kai H., Sugimachi M., Suzuki S., Takeshita A. J. Clin. Invest. 91:1993;29-37
19. Zei A.M., Drexler H., Saurbier B., Just H. J. Clin. Invest. 92:1993;652-662
20. Drexler H. Prog. Cardiovasc. Dis. 39:1997;287-324
21. Ribeiro M.O., Antunes E., Nicci G., Lovisolo S.M., Zatz R. Hypertension. 20:1992;298-303
22. Numaguchi K., Egashira K., Takemoto M., Kadokami T., Shimtokawa H., Sueshi K., Takeshita A. Hypertension. 26:1995;957-962
23. Takemoto M., Egashira K., Usui M., Numaguchi K., Tomita H., Tsutsui H., Shimokawa H., Sueshi K., Takeshita A. J. Clin. Invest. 99:1997;278-287
24. Colonna V.D.G., Rossoni G., Rigamonti A.E., Bonomo S., Manfredi B., Berti F., Muller E.E. Eur. J. Pharmacol. 450:2002;61-66
25. Hofmann K., Peckham W., Rheiner A. J. Am. Chem. Soc. 1:1956;238-242
26. Wang G.J., Shum A.Y.C., Lin Y.L., Liao J.F., Wu X.C., Ren J., Chen C.F. J. Pharmacol. Exp. Ther. 297:2001;240-246